Situated within the Department of Clinical Neuroscience and Preventive Medicine, the Center for Vascular Prevention focuses on research on primary and secondary prevention of vascular diseases. Non-communicable diseases (NCDs), in particular cerebrovascular and cardiovascular diseases, are nowadays globally the most common causes of death and of years lived with disabilities (LLD). Lifestyle-associated risk factors such as obesity or type II diabetes show a significantly increasing prevalence, both in rich and in low-income countries. Therefore, research in the field of vascular prevention is of high public health importance.
The research questions of the center are rigorously academic and focus on epidemiology of risk factors, influence of lifestyle and preventive management. National and international cooperation is a cornerstone of most of the projects.
• The Early Prevention of Diabetes Complications in Europe (e-PREDICE) study (completed by December 2017) examines the effects of pharmacological therapy (metformine or sitagliptine) in combination with lifestyle modification on macro- and microvascular, neurological and psychological outcomes in patients with type II Diabetes.
• The Austrian Polyintervention Study to Prevent Cognitive Decline after Ischemic Stroke (ASPIS) tested the potential benefits of a multimodal lifestyle-modifying program on cognitive abilities after a first stroke. Although statistically neutral, this study has provided valuable information for further study concepts on the highly important issue of a possible preventive therapy for vascular cognitive decline.
• Collaboration within the international project "Cut Stroke in Half - Polypill for Stroke Prevention" (in cooperation with the Center for Neuroscience)
• Scientific evaluations of the Austrian Stroke Unit Register (in cooperation with the Center for Neurosciences)
• Risk factor evaluation in patients with juvenile stroke